{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:43:23Z","timestamp":1784249003071,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1186\/bcr539","type":"journal-article","created":{"date-parts":[[2002,10,17]],"date-time":"2002-10-17T11:09:19Z","timestamp":1034852959000},"source":"Crossref","is-referenced-by-count":50,"title":["Progesterone receptors - animal models and cell signaling in breast cancer Diverse activation pathways for the progesterone receptor - possible implications for breast biology and cancer"],"prefix":"10.1186","volume":"4","author":[{"given":"Claudia","family":"Lanari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo A","family":"Molinolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,12,1]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1096\/fj.00-0165com","volume":"14","author":"TM Goepfert","year":"2000","unstructured":"Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D: Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J. 2000, 14: 2221-2229. 10.1096\/fj.00-0165com.","journal-title":"FASEB J"},{"key":"542_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Women's Health Initiative","year":"2002","unstructured":"Women's Health Initiative: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333.","journal-title":"JAMA"},{"key":"542_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000, 92: 328-332. 10.1093\/jnci\/92.4.328.","journal-title":"J Natl Cancer Inst"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0039-128X(00)00195-1","volume":"65","author":"JG Klijn","year":"2000","unstructured":"Klijn JG, Setyono-Han B, Foekens JA: Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer. Steroids. 2000, 65: 825-830. 10.1016\/S0039-128X(00)00195-1.","journal-title":"Steroids"},{"key":"542_CR5","first-page":"157","volume":"77","author":"C Lanari","year":"1986","unstructured":"Lanari C, Molinolo AA, Pasqualini CD: Inhibitory effect of medroxyprogesterone acetate on foreign body tumorigenesis in mice. J Natl Cancer Inst. 1986, 77: 157-164.","journal-title":"J Natl Cancer Inst"},{"key":"542_CR6","first-page":"1341","volume":"79","author":"AA Molinolo","year":"1987","unstructured":"Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD: Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J Natl Cancer Inst. 1987, 79: 1341-1350.","journal-title":"J Natl Cancer Inst"},{"key":"542_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ijc.2910430518","volume":"43","author":"C Lanari","year":"1989","unstructured":"Lanari C, Kordon E, Molinolo A, Pasqualini CD, Charreau EH: Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB\/c in vivo sublines. Int J Cancer. 1989, 43: 845-850.","journal-title":"Int J Cancer"},{"key":"542_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF01805741","volume":"12","author":"H Nagasawa","year":"1988","unstructured":"Nagasawa H, Aoki M, Sakagami N, Ishida M: Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice. Breast Cancer Res Treat. 1988, 12: 59-66.","journal-title":"Breast Cancer Res Treat"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00666353","volume":"28","author":"EC Kordon","year":"1993","unstructured":"Kordon EC, Molinolo AA, Pasqualini CD, Charreau EH, Pazos P, Dran G, Lanari C: Progesterone induction of mammary carcinomas in BALB\/c female mice. Correlation between progestin dependence and morphology. Breast Cancer Res Treat. 1993, 28: 29-39.","journal-title":"Breast Cancer Res Treat"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF01834643","volume":"20","author":"P Pazos","year":"1992","unstructured":"Pazos P, Lanari C, Meiss R, Charreau EH, Pasqualini CD: Mammary carcinogenesis induced by I-methyl-I-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB\/c mice. Breast Cancer Res Treat. 1992, 20: 133-138.","journal-title":"Breast Cancer Res Treat"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<126::AID-MC4>3.0.CO;2-D","volume":"17","author":"CM Aldaz","year":"1996","unstructured":"Aldaz CM, Liao QY, Paladugu A, Rehm S, Wang H: Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol Carcinog. 1996, 17: 126-133. 10.1002\/(SICI)1098-2744(199611)17:3<126::AID-MC4>3.0.CO;2-D.","journal-title":"Mol Carcinog"},{"key":"542_CR12","first-page":"4276","volume":"59","author":"JP Lydon","year":"1999","unstructured":"Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW: Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999, 59: 4276-4284.","journal-title":"Cancer Res"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1126\/science.156.3778.1050","volume":"156","author":"C Huggins","year":"1967","unstructured":"Huggins C: Endocrine-induced regression of cancers. Science. 1967, 156: 1050-1054.","journal-title":"Science"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1210\/mend.13.6.0290","volume":"13","author":"CA Lange","year":"1999","unstructured":"Lange CA, Richer JK, Horwitz KB: Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol. 1999, 13: 829-836. 10.1210\/me.13.6.829.","journal-title":"Mol Endocrinol"},{"key":"542_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0960-0760(99)00108-9","volume":"70","author":"C Lamb","year":"1999","unstructured":"Lamb C, Simian M, Molinolo A, Pazos P, Lanari C: Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation. J Steroid Biochem Mol Biol. 1999, 70: 133-142. 10.1016\/S0960-0760(99)00108-9.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1074\/jbc.M110090200","volume":"277","author":"JK Richer","year":"2002","unstructured":"Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002, 277: 5209-5218. 10.1074\/jbc.M110090200.","journal-title":"J Biol Chem"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1073\/pnas.97.7.3044","volume":"97","author":"G Shyamala","year":"2000","unstructured":"Shyamala G, Yang X, Cardiff RD, Dale E: Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA. 2000, 97: 3044-3049. 10.1073\/pnas.97.7.3044.","journal-title":"Proc Natl Acad Sci USA"},{"key":"542_CR18","first-page":"321","volume":"20","author":"NJ McKenna","year":"1999","unstructured":"McKenna NJ, Lanz RB, O'Malley BW: Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999, 20: 321-344. 10.1210\/er.20.3.321.","journal-title":"Endocr Rev"},{"key":"542_CR19","first-page":"291","volume":"54","author":"PH Giangrande","year":"1999","unstructured":"Giangrande PH, McDonnell DP: The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog Horm Res. 1999, 54: 291-313.","journal-title":"Recent Prog Horm Res"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1210\/mend.14.1.0413","volume":"14","author":"DL Clemm","year":"2000","unstructured":"Clemm DL, Sherman L, Boonyaratanakornkit V, Schrader WT, Weigel NL, Edwards DP: Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol. 2000, 14: 52-65. 10.1210\/me.14.1.52.","journal-title":"Mol Endocrinol"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF00683192","volume":"27","author":"DP Edwards","year":"1993","unstructured":"Edwards DP, Weigel NL, Nordeen SK, Beck CA: Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat. 1993, 27: 41-56.","journal-title":"Breast Cancer Res Treat"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"27793","DOI":"10.1074\/jbc.M202584200","volume":"277","author":"BM Jacobsen","year":"2002","unstructured":"Jacobsen BM, Richer JK, Schittone SA, Horwitz KB: New human breast cancer cells to study progesterone receptor (PR) isoform ratio effects and ligand-independent gene regulation. J Biol Chem. 2002, 277: 27793-27800. 10.1074\/jbc.M202584200.","journal-title":"J Biol Chem"},{"key":"542_CR23","first-page":"24","volume-title":"In Proceedings of the AACR, New Orleans. Buenos Aires: Instituto de Biolog\u00eda y Medicina Experimental, and Facultad de Ciencias Exactas y Naturales, UBA; March","author":"P Elizalde","year":"2001","unstructured":"Elizalde P, Labriola L, Salatino M, Movsichoff F, Proietti C, Pecci A, Coso O, Kornblihtt A, Charreau E: Heregulin regulates the progesterone receptor (Pr) transcriptional activity by a mechanism that requires a functional erbB-2 and mitogen-activated protein kinases (MAPK) activation. In Proceedings of the AACR, New Orleans. Buenos Aires: Instituto de Biolog\u00eda y Medicina Experimental, and Facultad de Ciencias Exactas y Naturales, UBA; March. 2001, 24-28."},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","volume":"17","author":"A Migliaccio","year":"1998","unstructured":"Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F: Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via crosstalk with estrogen receptor. EMBO J. 1998, 17: 2008-2018. 10.1093\/emboj\/17.7.2008.","journal-title":"EMBO J"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1073\/pnas.98.1.8","volume":"98","author":"JL Maller","year":"2001","unstructured":"Maller JL: The elusive progesterone receptor in Xenopus oocytes. Proc Natl Acad Sci USA. 2001, 98: 8-10. 10.1073\/pnas.98.1.8.","journal-title":"Proc Natl Acad Sci USA"},{"key":"542_CR26","first-page":"1441","volume":"47","author":"S Bardon","year":"1987","unstructured":"Bardon S, Vignon F, Montcourrier P, Rochefort H: Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Research. 1987, 47: 1441-1448.","journal-title":"Cancer Research"},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/carcin\/23.5.749","volume":"23","author":"S Vanzulli","year":"2002","unstructured":"Vanzulli S, Efeyan A, Benavides F, Helguero L, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A: p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis. 2002, 23: 749-757. 10.1093\/carcin\/23.5.749.","journal-title":"Carcinogenesis"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF01236387","volume":"120","author":"Y Nishino","year":"1994","unstructured":"Nishino Y, Schneider MR, Michna H: Enhancement of the anti-tumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384. J Cancer Res Clin Oncol. 1994, 120: 298-302.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr539\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T11:59:22Z","timestamp":1484740762000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1186\/bcr539","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"article-number":"240"}}